Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology

Youssef, Mohamed; van der Veen, Fulco; Al-Inany, Hesham; H. Mochtar, Monique; Griesinger, Georg; N. Mohesen, Mohamed; Aboulfoutouh, Ismail; van Wely, Madelon

doi:10.1002/14651858.cd008046.pub4

Public

Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology

Published in Cochrane Database of Systematic Reviews • Oct 31, 2014

Authors:

Mohamed Youssef

Fulco van der Veen

Hesham Al-Inany

Abstract

BACKGROUND: Human chorionic gonadotropin (HCG) is routinely used for final oocyte maturation triggering in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles, but the use of HCG for this purpose may have drawbacks. Gonadotropin-releasing hormone (GnRH) agonists present an al...

Subject

Gonadotropin-releasing hormone antagonist

Intracytoplasmic sperm injection

Hormone antagonist

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!